Orange Book product · Brand (NDA)
ROCURONIUM BROMIDE
ROCURONIUM BROMIDE
At a glance
Oct 24, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 24, 2025
8 mo ago
Today
Patent 11998605 expires
Listed drug product patent expiration.
Jul 22, 2039
in 13 yr 3 mo
Pharmaceutical detail
Active ingredient
ROCURONIUM BROMIDE
Strength
50MG/5ML (10MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 219108
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025ROCURONIUM BROMIDEBrand (NDA)
NDA 217472 · FRESENIUS KABI USA
- 1994ZEMURONBrand (NDA)
NDA 020214 · ORGANON USA INC
- 2026ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 220124 · ASPIRO
- 2026ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 213476 · KNACK
- 2025ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 219674 · MANKIND PHARMA
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 217092 · STERISCIENCE
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 204918 · RISING
- 2024ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 215684 · SHANDONG
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 217034 · HIKMA
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 213453 · MEITHEAL
- 2023ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 216234 · CAPLIN
- 2022ROCURONIUM BROMIDEGeneric (ANDA)
ANDA 212668 · PRINSTON INC
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11998605 | Jul 22, 2039 | in 13 yr 3 mo | Product |

